Biohealth Italia

Biohealth Italia is an Italian pharmaceutical and nutraceutical company specializing in the research and development of products for nephrology and urology. The company is a leader in the management of kidney stones (nephrolithiasis) and urinary pH balance, offering a range of medical devices and food supplements designed to prevent stone recurrence and correct metabolic imbalances. Their portfolio is built around mineral salts and citrate-based therapies that address conditions like hypocitraturia and metabolic acidosis. In 2021, the company was acquired by Giellepi S.p.A., a major Italian player in the health supplement sector, to strengthen its presence in the specialist medical channel. Biohealth Italia continues to operate as a specialized unit focusing on high-quality clinical evidence for its metabolic health products.